Cormedix Inc (CRMD)
5.52
+0.26
(+5.04%)
USD |
NASDAQ |
May 01, 16:00
5.515
0.00 (0.00%)
After-Hours: 20:00
Cormedix Cash from Operations (Quarterly): -10.75M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.75M |
| September 30, 2023 | -8.698M |
| June 30, 2023 | -8.572M |
| March 31, 2023 | -10.39M |
| December 31, 2022 | -6.155M |
| September 30, 2022 | -5.995M |
| June 30, 2022 | -5.462M |
| March 31, 2022 | -6.744M |
| December 31, 2021 | -5.869M |
| September 30, 2021 | -5.504M |
| June 30, 2021 | -3.092M |
| March 31, 2021 | -6.691M |
| December 31, 2020 | -5.934M |
| September 30, 2020 | -7.313M |
| June 30, 2020 | -0.7544M |
| March 31, 2020 | -7.967M |
| December 31, 2019 | -3.885M |
| September 30, 2019 | -3.964M |
| June 30, 2019 | 0.1645M |
| March 31, 2019 | -7.368M |
| December 31, 2018 | -7.200M |
| September 30, 2018 | -5.111M |
| June 30, 2018 | -4.336M |
| March 31, 2018 | -7.054M |
| December 31, 2017 | -7.277M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.800M |
| June 30, 2017 | -7.751M |
| March 31, 2017 | -6.759M |
| December 31, 2016 | -6.498M |
| September 30, 2016 | -6.549M |
| June 30, 2016 | -3.768M |
| March 31, 2016 | -5.451M |
| December 31, 2015 | -3.635M |
| September 30, 2015 | -2.945M |
| June 30, 2015 | -3.599M |
| March 31, 2015 | -2.348M |
| December 31, 2014 | -1.574M |
| September 30, 2014 | -1.811M |
| June 30, 2014 | -1.506M |
| March 31, 2014 | -1.429M |
| December 31, 2013 | -0.9232M |
| September 30, 2013 | -1.518M |
| June 30, 2013 | -0.5593M |
| March 31, 2013 | -0.6178M |
| December 31, 2012 | -0.5283M |
| September 30, 2012 | -0.6716M |
| June 30, 2012 | -0.9463M |
| March 31, 2012 | -0.1301M |
| December 31, 2011 | -0.9046M |
| September 30, 2011 | -1.848M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.75M
Minimum
Dec 2023
0.1645M
Maximum
Jun 2019
-5.978M
Average
-5.995M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| BioXcel Therapeutics Inc | -26.86M |
| Assertio Holdings Inc | 5.707M |
| Verastem Inc | -29.68M |
| Ocular Therapeutix Inc | -22.45M |
| PAVmed Inc | -11.87M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.5978M |
| Cash from Financing (Quarterly) | 0.4677M |
| Free Cash Flow | -38.74M |
| Free Cash Flow Per Share (Quarterly) | -0.1921 |
| Free Cash Flow Yield | -13.80% |